Related Experiment Video
Updated: Jun 19, 2026

08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Knowledge of residual curarization: an Italian survey
P Di Marco1, G Della Rocca, F Iannuccelli
1Department of Anesthesia and Intensive Care Medicine, University of Rome La Sapienza, Rome, Italy. pierangelo.dimarco@uniroma1.it
Acta Anaesthesiologica Scandinavica
|October 21, 2009
Summary
Most Italian anesthesiologists rely on clinical signs, not quantitative monitoring, to assess neuromuscular blockade recovery. This highlights a gap in awareness regarding residual paralysis, impacting patient safety.
Area of Science:
- Anesthesiology
- Pharmacology
- Patient Safety
Background:
- Neuromuscular blocking agents (NMBAs) are crucial in anesthesia, but their current usage patterns in Italy are not well-documented.
- Understanding monitoring practices for neuromuscular blockade recovery is essential for preventing post-operative complications.
Purpose of the Study:
- To survey Italian anesthesiologists on their methods for assessing neuromuscular blockade recovery.
- To determine the reliability of clinical tests versus quantitative monitoring (e.g., train-of-four ratio).
- To estimate the incidence of post-operative paralysis in Italian hospitals.
Main Methods:
- A questionnaire was distributed to Italian anesthesiologists at a national congress.
- Data were collected and stratified by anesthesiologist age and hospital surgical volume.
- Response rate was 88.7%, with 754 valid questionnaires.
Main Results:
- 73% of respondents exclusively used clinical tests (head lift, tongue protrusion, eye opening) to monitor neuromuscular blockade.
- Only 35% routinely used train-of-four (TOF) monitoring.
- A TOF ratio of 0.9 for extubation was reported by only 24% of anesthesiologists.
Conclusions:
- The majority of Italian anesthesiologists depend on subjective clinical assessments for neuromuscular blockade recovery.
- There is a significant lack of awareness regarding the limitations of clinical tests in detecting residual neuromuscular block.
- Increased adoption of quantitative monitoring is recommended for safer NMBA use and improved patient outcomes.

